drugset / Trial / NCT03024957
Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity
RandomizedParallel-groupDouble-blindTreatment
Summary
this work aims to investigate the effect of intrathecal administration of Morphine, Dexmedetomidine or both in combination on cellular immunity and cytokine production in patients undergoing major abdominal cancer surgeries.
Timeline
- Start
- 2017-01
- Primary completion
- 2018-09
- Completion
- 2021-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 5 ug | Intrathecal |
| Comparator | Morphine | Other / unclassified | 0.5 mg | Intrathecal |
| Comparator | Bupivacaine | Other / unclassified | 10 mg | Intrathecal |